Advances in biosensors and diagnostic technologies using nanostructures and nanomaterials

EC Welch, JM Powell, TB Clevinger… - Advanced Functional …, 2021 - Wiley Online Library
Nanoscale materials have unique properties that make them especially useful for
biomedical diagnostic applications. Recent developments in nanoengineering have resulted …

[HTML][HTML] Nanomedicines for cardiovascular disease

BR Smith, ER Edelman - Nature Cardiovascular Research, 2023 - nature.com
The leading cause of death in the world, cardiovascular disease (CVD), remains a
formidable condition for researchers, clinicians and patients alike. CVD comprises a broad …

Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis

J Chen, X Zhang, R Millican, J Sherwood… - Advanced drug delivery …, 2021 - Elsevier
Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries,
leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is …

[HTML][HTML] Exploring the potential of nanosensors: A brief overview

M Javaid, A Haleem, RP Singh, S Rab, R Suman - Sensors International, 2021 - Elsevier
Nanosensors are now being used to detect and monitor physical characteristics such as the
temperature at nanoscale, with chemical species and nanoparticles. It is nanoscale devices …

[HTML][HTML] Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs

B Perera, Y Wu, NT Nguyen, HT Ta - Materials Today Bio, 2023 - Elsevier
Atherosclerosis is the build-up of fatty deposits in the arteries. Atherosclerosis is the main
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …

A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis

KX Vazquez‐Prada, SS Moonshi, Y Wu, F Akther… - Small, 2023 - Wiley Online Library
Thrombosis and its complications are responsible for 30% of annual deaths. Limitations of
methods for diagnosing and treating thrombosis highlight the need for improvements …

Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles

KX Vazquez-Prada, J Lam, D Kamato… - … and Vascular Biology, 2021 - Am Heart Assoc
Cardiovascular disease is one of the major contributors to global disease burden.
Atherosclerosis is an inflammatory process that involves the accumulation of lipids and …

Poly (aspartic acid) in biomedical applications: From polymerization, modification, properties, degradation, and biocompatibility to applications

H Adelnia, HDN Tran, PJ Little, I Blakey… - … Biomaterials Science & …, 2021 - ACS Publications
Poly (aspartic acid)(PASP) is an anionic polypeptide that is a highly versatile, biocompatible,
and biodegradable polymer that fulfils key requirements for use in a wide variety of …

[HTML][HTML] Recent advances in the development of theranostic nanoparticles for cardiovascular diseases

Y Wu, KX Vazquez-Prada, Y Liu, AK Whittaker… - …, 2021 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …

Harnessing nanotechnology for cardiovascular disease applications-a comprehensive review based on bibliometric analysis

Z Zheng, S Zhu, M Lv, Z Gu, H Hu - Nano Today, 2022 - Elsevier
Cardiovascular diseases (CVDs) remain the leading cause of health problems worldwide.
Nanotechnology, based on its unique properties, provides novel solutions to the diagnosis …